PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 187 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401 | -19.8% | 13,064 | +4.8% | 0.00% | 0.0% |
| Q2 2023 | $500 | -13.3% | 12,467 | -11.8% | 0.00% | -25.0% |
| Q1 2023 | $577 | -99.9% | 14,135 | +29.9% | 0.00% | 0.0% |
| Q3 2022 | $579,000 | +38.2% | 10,885 | +51.6% | 0.00% | +33.3% |
| Q2 2022 | $419,000 | -40.1% | 7,181 | -21.6% | 0.00% | -25.0% |
| Q1 2022 | $699,000 | +36.8% | 9,165 | +7.8% | 0.00% | +100.0% |
| Q4 2021 | $511,000 | +30.4% | 8,499 | +21.4% | 0.00% | 0.0% |
| Q3 2021 | $392,000 | +22.1% | 7,000 | +32.2% | 0.00% | 0.0% |
| Q2 2021 | $321,000 | +2.2% | 5,295 | +18.0% | 0.00% | 0.0% |
| Q1 2021 | $314,000 | +43.4% | 4,487 | +22.4% | 0.00% | +100.0% |
| Q4 2020 | $219,000 | -6.8% | 3,666 | -23.5% | 0.00% | -50.0% |
| Q3 2018 | $235,000 | -11.3% | 4,790 | -42.0% | 0.00% | 0.0% |
| Q2 2018 | $265,000 | -5.4% | 8,256 | -8.2% | 0.00% | 0.0% |
| Q1 2018 | $280,000 | -56.0% | 8,994 | -35.6% | 0.00% | -50.0% |
| Q4 2017 | $637,000 | +264.0% | 13,964 | +169.4% | 0.00% | +300.0% |
| Q2 2016 | $175,000 | -27.7% | 5,184 | +13.6% | 0.00% | -50.0% |
| Q1 2016 | $242,000 | -8.7% | 4,562 | +32.1% | 0.00% | 0.0% |
| Q4 2015 | $265,000 | +44.0% | 3,453 | -22.8% | 0.00% | +100.0% |
| Q3 2015 | $184,000 | +93.7% | 4,471 | +233.9% | 0.00% | 0.0% |
| Q2 2015 | $95,000 | -89.5% | 1,339 | -86.8% | 0.00% | -85.7% |
| Q1 2015 | $901,000 | +890.1% | 10,145 | +883.0% | 0.01% | +600.0% |
| Q4 2014 | $91,000 | -17.3% | 1,032 | -9.3% | 0.00% | 0.0% |
| Q3 2014 | $110,000 | +2.8% | 1,138 | -2.7% | 0.00% | 0.0% |
| Q2 2014 | $107,000 | +46.6% | 1,169 | +11.8% | 0.00% | 0.0% |
| Q1 2014 | $73,000 | +19.7% | 1,046 | -1.0% | 0.00% | 0.0% |
| Q4 2013 | $61,000 | -64.3% | 1,057 | -70.2% | 0.00% | -50.0% |
| Q3 2013 | $171,000 | +210.9% | 3,548 | +87.6% | 0.00% | +100.0% |
| Q2 2013 | $55,000 | – | 1,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |